Retreatment of Hepatitis C with Consensus Interferon and Ribavirin After Nonresponse or Relapse to Pegylated Interferon and Ribavirin: A National VA Clinical Practice Study
- نوع فایل : کتاب
- زبان : انگلیسی
- مؤلف : Helen S. Yee Sue L. Currie Kathryn Tortorice Myrna Cozen Hui Shen Summer Chapman Fran Cunningham Alexander Monto
- چاپ و سال / کشور: 2011
Description
Background Studies of the retreatment with consensus interferon (CIFN) and ribavirin (RBV) of hepatitis C virus (HCV)-infected patients who failed prior pegylated interferon alfa/ribavirin (PEG-IFN/RBV) have found quite variable efficacy and tolerability of this therapy. As such, CIFN/RBV use and efficacy in clinical practice were evaluated within the Department of Veterans Affairs (VA), the largest national, integrated system for HCV care. Aims The purpose of this study was to determine rates of sustained virologic response (SVR) and patterns of CIFN/ RBV use in the VA. Methods included retrospective review of national VA data in HCV-infected patients who had previously failed C12 weeks of PEG-IFN/RBV and were prescribed CIFN/RBV between October 1, 2003 and September 30, 2006. Results A total of 597 patients met the study criteria. CIFN was primarily dosed as 15 mcg subcutaneously daily combined with standard doses of RBV. Mean treatment duration was 21 weeks; CIFN was discontinued within 4 weeks in 24%. Hematological growth factors were used in 49%. Post-treatment viral loads were available in 385 patients. SVR to CIFN/RBV was achieved in 11%, and was significantly higher in prior PEG-IFN/RBV relapsers compared with nonresponders (31% vs. 6%, respectively; P\0.0001). A 2-log10 or greater drop in HCV RNA after 24 weeks of PEG-IFN/RBV was a predictor of subsequent SVR to CIFN/RBV. Conclusions CIFN/RBV was used frequently in clinical practice for retreatment of PEG-IFN/RBV. In this setting, early treatment discontinuation was common. Overall SVR was low, although response was significantly better in prior PEG-IFN/RBV relapsers and those who had a 2-log10 or greater decline than in nonresponders.
Dig Dis Sci (2011) 56:2439–2448 DOI 10.1007/s10620-011-1746-3 Received: 16 December 2010 / Accepted: 3 May 2011 / Published online: 2 June 2011
